- Home
- RMI vs EDAP Comparison
RMI vs EDAP Comparison
Compare RMI & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMI
- EDAP
- Stock Information
- Founded
- RMI 2018
- EDAP 1979
- Country
- RMI United States
- EDAP France
- Employees
- RMI N/A
- EDAP N/A
- Industry
- RMI Finance/Investors Services
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RMI Finance
- EDAP Health Care
- Exchange
- RMI Nasdaq
- EDAP Nasdaq
- Market Cap
- RMI 100.2M
- EDAP 81.6M
- IPO Year
- RMI N/A
- EDAP 1997
- Fundamental
- Price
- RMI $15.58
- EDAP $2.32
- Analyst Decision
- RMI
- EDAP Strong Buy
- Analyst Count
- RMI 0
- EDAP 1
- Target Price
- RMI N/A
- EDAP $19.00
- AVG Volume (30 Days)
- RMI 17.4K
- EDAP 230.9K
- Earning Date
- RMI 01-01-0001
- EDAP 11-07-2024
- Dividend Yield
- RMI 7.28%
- EDAP N/A
- EPS Growth
- RMI N/A
- EDAP N/A
- EPS
- RMI N/A
- EDAP N/A
- Revenue
- RMI N/A
- EDAP $70,722,730.00
- Revenue This Year
- RMI N/A
- EDAP $6.96
- Revenue Next Year
- RMI N/A
- EDAP $15.53
- P/E Ratio
- RMI N/A
- EDAP N/A
- Revenue Growth
- RMI N/A
- EDAP 12.17
- 52 Week Low
- RMI $13.05
- EDAP $2.14
- 52 Week High
- RMI $17.37
- EDAP $8.50
- Technical
- Relative Strength Index (RSI)
- RMI 36.73
- EDAP 45.48
- Support Level
- RMI $15.45
- EDAP $2.14
- Resistance Level
- RMI $16.14
- EDAP $2.47
- Average True Range (ATR)
- RMI 0.20
- EDAP 0.15
- MACD
- RMI -0.05
- EDAP 0.02
- Stochastic Oscillator
- RMI 10.08
- EDAP 33.96
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.